Foundation Medicine Launches RNA Sequencing Test
Foundation Medicine launched a tissue-based RNA sequencing test in the U.S. for the detection of cancer-related fusions across 318 genes.
Read More
Search Results for: liver disease
Non-Invasive Liver Disease Blood Test Hits the U.S. Market
Luxor Scientific and CIMA Sciences have launched OWLiver, a non-invasive blood test to detect all stages of metabolic liver disease.
Read More
Mainz Biomed Colorectal Cancer Diagnostic Part of FDA Trial
Mainz Biomed N.V. announced results from a clinical study to evaluating integrating its portfolio into its colorectal cancer screening tool.
Read More
DELFI Collaborates with Hospital System to Improve Lung Cancer Screening
OSF HealthCare will use DELFI’s FirstLook Lung blood test to enhance lung cancer screening rates and early detection efforts.
Read More
QIAGEN Gets FDA Clearance for Respiratory Syndromic Test Panel
QIAGEN’s QIAstat-Dx Respiratory Panel Plus, a syndromic testing tool for diagnosing respiratory infections, received FDA clearance.
Read More